17th Feb 2014 10:35
LONDON (Alliance News) - Benchmark Holdings PLC Monday said it has acquired aquaculture vaccine and development assets from animal health company Zoetis Inc. for USD3 million in cash, a deal it claims will significantly advance its aquaculture research programmes and compliment its existing research base.
New Jersey-headquartered Zoetis Inc. is one of the world's largest producer of medicine and vaccinations for pets and livestock.
Benchmark said the deal will see it acquire a worldwide licence to utilise Zoetis' expertise, helping it drive the future research and development of the aquaculture vaccines it is acquiring.
In addition to vaccine research and manufacturing equipment, the portfolio acquired includes a number of developed and partially developed vaccines, seed stocks, isolates and vaccine technologies.
The stock was trading at 126.00 pence Monday morning, up 1.50 pence or 1.2%.
By Anthony Tshibangu; [email protected]; @AnthonyAllNews
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Benchmark Holdings